Researchers recently tested ChatGPT’s ability to answer patient questions about medication, finding that the viral chatbot came up dangerously short. The research was presented at the American Society of Health-System Pharmacists’ annual meeting, which…
Continue Reading
A study done by Google Research in collaboration with Google DeepMind reveals the tech giant developed an LLM with conversational and collaborative capabilities that can provide an accurate differential diagnosis (DDx) and help improve…
Continue Reading
Hospital administrators are constantly inundated with pitches from AI companies claiming that they can solve healthcare’s myriad inefficiencies. On Thursday, three health system leaders came together for a webinar to discuss strategies they use…
Continue Reading
The growing power of AI has sparked considerable enthusiasm as well as apprehension in many industries, and healthcare is no exception. With the potential to reshape healthcare delivery, AI holds the promise of offering…
Continue Reading
The path to market and to a meaningful impact on care delivery for medical extended reality (MXR) is challenging, due to limitations with current display technologies and as the MXR approach is far away…
Continue Reading
Motor Neuron Disease (MND) is a progressive and largely fatal neurodegeneritve disorder with a lifetime risk of approximately 1 in 300. At diagnosis, up to 25% of people with MND (pwMND) exhibit bulbar dysfunction….
Continue Reading
Sarah Jones, Chief Outcomes Officer at b.well Connected Health What You Should Know: – b.well Connected Health, the leading platform for unified consumer health experiences, announced the appointment of Sarah Jones as its Chief…
Continue Reading
Leaders in the digital health space relayed to MobiHealthNews what stood out to them in 2023 as the year draws to an end.Many noted the meteoric rise of genAI in 2023 and expectations of…
Continue Reading
What You Should Know:
Insilico Medicine (“Insilico”), a generative artificial intelligence (AI)-driven clinical-stage biotechnology company, today announced that the company has initiated the first-in-human study for ISM5411, a potentially first-in-class PHD inhibitor for the treatment…
Continue Reading
What You Should Know: Yseop, a world-leading Generative AI company for life sciences, today announces the closing of a strategic investment round, with new investor Novartis (dRx Capital), joining existing investors Eli Lilly, NextStage…
Continue Reading
